Thinking of joining a study?

Register your interest

NCT04529967 | NOT YET RECRUITING | Familial Hypercholesterolemia


Child-Parent Familial Hypercholesterolemia Screening
Sponsor:

Children's Hospital of Fudan University

Brief Summary:

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scitific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetc screening.

Condition or disease

Familial Hypercholesterolemia

Intervention/treatment

no interventions

Detailed Description:

Familial hypercholesterolemia (FH) is an inherited condition resulting in high levels of low-density lipoprotein cholesterol (LDL-C) and increased risk of premature coronary artery disease in men and women. Child-parent screening for familial hypercholesterolemia has been proposed to identify persons who are carriers of FH mutations and with high risk for inherited premature coronary artery disease. The investigators will conduct a cross-sectional community-based screening in children of 2 years old to detect FH children cases using finger blood TC test first and followed by serum TC test and mutation test, and to identify and diagnose their affected parents. This study aims to established the Child-parent screening program and technique issues for early diagnosis of familial hypercholesterolemia families for future early intervention. Child-parent screening strategy in our study consists three steps: i. Apillary blood total cholesterol test of children aged around 2 years; ii. re-test for children with cholesterol\>95th percentile in the first step; iii. WES (whole exome sequencing) test for \>P99 in the first two steps. iV: TC test and mutation test to the parents of the child FH cases. The investigators will determine FH families based on the program. Children's Hospital of Fudan University will provide treatment further.

Study Type : OBSERVATIONAL
Estimated Enrollment : 15000 participants
Official Title : Child-Parent Screening of Familial Hypercholesterolemia in Children
Actual Study Start Date : 2025-04-01
Estimated Primary Completion Date : 2026-09-30
Estimated Study Completion Date : 2026-09-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 1 Year to 3 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Receive routine child care
  • * aged 1 - 3 years old ( date of investigate minus date of birth)
Exclusion Criteria
  • * It is up to the researcher to decide whether it is suitable to participate in this research

Child-Parent Familial Hypercholesterolemia Screening

Location Details

NCT04529967


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...